Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

NCT04681248 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Esophageal Neoplasm
Adenocarcinoma of the Gastroesophageal Junction
GastroEsophageal Cancer
Squamous Cell Carcinoma
Gastric Adenocarcinoma
Endometrial Cancer
Uterine Cancer
Ovarian Cancer
Carcinosarcoma
Gastric Cancer

Interventions

DRUG: DKN-01

Sponsor

Leap Therapeutics, Inc.